Should the FDA approval process for weight-loss drugs be modified?
Center for Weight Management, Roseville, CA 95661, USA. edhendricks@surewest.net
Ed J
EJ
Hendricks
D000818:Animals; D019440:Anti-Obesity Agents / Q000627:therapeutic use*; D001552:Benzazepines / Q000627:therapeutic use*; D006801:Humans; D009765:Obesity / Q000188:drug therapy*
D019440:Anti-Obesity Agents; D001552:Benzazepines; C506658:lorcaserin